News & Events
< Back to News Overview
CogState Announces United States Patent Approval
25 / 07 / 2006
CogState is pleased to announce that it has received a Notice of Allowance from the Unites States Patent & Trade Mark Office for CogState's key technology platform, used in the computer based tests of cognition that form the basis of its business (patent application US 10/343,067).
The patent, when granted, will broadly protect a psychological testing method which randomises the nature and timing of the visual stimuli presented to a subject as well as the apparatus used in such tests. The patent will also protect the company''s unique approach to cross cultural and non language specific based testing which uses acultural visual stimuli.
The technology covered by the patent is used in CogState's computer based tests of cognition. CogState has sold, and is continuing to sell, these tests to pharmaceutical companies such as Pfizer, GlaxoSmithKline, Alza Corporation and Organon USA.
This is the first patent issued to CogState in the United States. Patent 2001275604 was issued in Australia in April 2005.
The patent, when granted, will broadly protect a psychological testing method which randomises the nature and timing of the visual stimuli presented to a subject as well as the apparatus used in such tests. The patent will also protect the company''s unique approach to cross cultural and non language specific based testing which uses acultural visual stimuli.
The technology covered by the patent is used in CogState's computer based tests of cognition. CogState has sold, and is continuing to sell, these tests to pharmaceutical companies such as Pfizer, GlaxoSmithKline, Alza Corporation and Organon USA.
This is the first patent issued to CogState in the United States. Patent 2001275604 was issued in Australia in April 2005.